Semintra: The pH, appearance and assay is out of specification in the affected lot.
Last updated
Summary
Product
Semintra
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Semintra |
Semintra |
DIN 02418126 |
Solution |
Telmisartan - 4 mg/mL Oral Solution |
F11187 |
Issue
The pH, appearance and assay is out of specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Distributors
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Veterinary drugs
Companies
|
Boehringer Ingelheim Animal Health Canada Inc. 5180 South Service Road, Burlington, Ontario, L7L5H4 |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-74474
Get notified
Receive notifications for new and updated recalls and alerts by category.